About CSL
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Melbourne, Victoria
- Company type
- Public Company
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies.
Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest.
See our community guidelines: https://bit.ly/3Bs17Ra
Specialties
- Complex biologicals
- vaccines
- plasma and plasma derived therapeutics
- biotechnology
- and biopharma
Company locations
655 Elizabeth St, Melbourne, Victoria 3000, AU
1020 1st Ave, King of Prussia, PA 19406, US
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
Business areas
- Health Diagnostics
- Health Care
- Biotechnology
- Medical
- Biotech & Pharmaceuticals
- Pharmaceutical and biotechnology
On LinkedIn
- Followers
- 324,818
- People linked to this company
- 23,091
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
111,000,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.